Skip to content

Clinical trials

Phase 2 Gastroesophageal Reflux trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Phase 2 Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20053
20064
20074
20084
20095
20108
20124
20135
20141
20151
20163
20172
20181
20191
20202
20212
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Terminated8
Unknown status4
Recruiting2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Takeda5
Addex Pharma S.A.2
Eisai Inc.2
Ironwood Pharmaceuticals, Inc.2
Johns Hopkins University2
Shire2
XenoPort, Inc.2
Assistance Publique - Hôpitaux de Paris1
Baylor College of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux60
Heartburn8
Asthma3
Deglutition Disorders3
Gastroparesis3
Barrett Esophagus2
Dyspepsia2
Esophagitis2
Esophagitis, Peptic2
Pancreatitis2

Trials

Showing 76 to 60 of 60. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.